MétaCan
Menu
Back to cohort
Record W2887053618 · doi:10.1111/bph.14472

Efficacy of treprostinil in the SU5416‐hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling

2018· article· en· W2887053618 on OpenAlexafffund
Ketul R. Chaudhary, Yupu Deng, Colin Suen, Mohamad Taha, Thomas Petersen, Shirley H. J. Mei, Duncan J. Stewart

Bibliographic record

VenueBritish Journal of Pharmacology · 2018
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsOttawa HospitalUniversity of Ottawa
FundersCanadian Institutes of Health ResearchUnited Therapeutics Corporation
KeywordsTreprostinilRight ventricular hypertrophyMedicinePulmonary hypertensionHemodynamicsCardiologyInternal medicineVentricular pressureHypoxia (environmental)Muscle hypertrophyBlood pressureChemistry

Abstract

fetched live from OpenAlex

Background and Purpose Pulmonary arterial hypertension (PAH) is a life‐threatening disease that leads to progressive pulmonary hypertension, right heart failure and death. Parenteral prostaglandins (PGs), including treprostinil, a prostacyclin analogue, represent the most effective medical treatment for severe PAH. We investigated the effect of treprostinil on established severe PAH and underlying mechanisms using the rat SU5416 (SU, a VEGF receptor‐2 inhibitor)‐chronic hypoxia (Hx) model of PAH. Experimental Approach Male Sprague Dawley rats were injected with SU (20 mg·kg −1 , s.c.) followed by 3 weeks of Hx (10% O 2 ) to induce severe PAH. Four weeks post‐SU injection, baseline right ventricular (RV) systolic pressure (RVSP) was measured, and the rats were randomized to receive vehicle or treprostinil treatment (Trep‐100: 100 ng·kg −1 ·min −1 or Trep‐810: 810 ng·kg −1 ·min −1 ). Following 3 weeks of treatment, haemodynamic and echocardiographic assessments were performed, and tissue samples were collected for protein expression and histological analysis. Key Results At week 7, no difference in RVSP or RV hypertrophy was observed between vehicle and Trep‐100; however, Trep‐810 significantly reduced RVSP and RV hypertrophy. Trep‐810 treatment significantly improved cardiac structure and function. Further, a short‐term infusion of treprostinil in rats with established PAH at 4 weeks post‐SU produced an acute, dose‐dependent reduction in RVSP consistent with a vasodilator effect. However, chronic Trep‐810 treatment did not alter media wall thickness, degree of vascular occlusion or total vessel count in the lungs. Conclusions and Implications Treprostinil exerts therapeutic benefits in PAH through decreased vascular resistance and improved cardiac structure and function; however, treprostinil treatment does not have direct impact vascular remodelling.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.044
GPT teacher head0.295
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of PharmacologySame topicPulmonary Hypertension Research and TreatmentsFrench-language works237,207